Amplifying Apoptosis Homing Nanoplatform for Tumor Theranostics

Area of Science:

• Nanomedicine
• Biomaterials Science
• Oncology

Background:

• Current nanomedicine for cancer theranostics faces limitations due to poor nanoparticle accumulation and insufficient tumor cell receptor targeting.
• Enhanced permeability and retention (EPR) effect is often limited, impacting therapeutic outcomes.
• Developing targeted delivery systems is crucial for improving cancer treatment efficacy.

Purpose of the Study:

• To develop an apoptosis-homing nanoplatform for enhanced cancer theranostics.
• To improve nanoparticle accumulation and specificity in tumors.
• To combine magnetic resonance imaging (MRI) and photothermal therapy (PTT) for improved tumor treatment.

Main Methods:

• Synthesis of iron(II)/iron(III) oxide nanoparticles (MNPs) conjugated with zinc(II) dipicolylamine (ZnDPA).
• Utilizing the affinity of ZnDPA for phosphatidylserine (PS) on apoptotic cancer cells for targeted accumulation.
• Evaluating the nanoplatform in an apoptotic xenograft model induced by doxorubicin.

Main Results:

• The MNPs/ZnDPA nanoplatform showed a two-fold increase in accumulation in apoptotic tumors.
• Significant decrease in T2 values (tumor/muscle ratio reduced by 50%) indicating enhanced MRI signal in tumors.
• Amplified photothermal therapy confirmed by reduced tumor volume and positive TdT-mediated dUTP nick-end labeling (TUNEL) staining.

Conclusions:

• The developed MNPs/ZnDPA nanoplatform effectively targets apoptotic cancer cells via ZnDPA-PS interaction.
• This nanoplatform enhances theranostic efficacy through improved targeting and amplified photothermal therapy.
• This strategy offers a promising approach for improving nanoparticle targeting and enhancing tumor-targeting theranostics.